- Home
- OSUR vs AQST Comparison
OSUR vs AQST Comparison
Compare OSUR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | AQST |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.9M | 504.0M |
| IPO Year | 2000 | 2007 |
Fundamental Metrics
Financial Performance| Metric | OSUR | AQST |
|---|---|---|
| Price | $2.99 | $4.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.00 | ★ $9.00 |
| AVG Volume (30 Days) | 509.3K | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,064,000.00 | $67,430,000.00 |
| Revenue This Year | $4.48 | $10.08 |
| Revenue Next Year | $7.76 | $49.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $2.08 | $2.22 |
| 52 Week High | $3.76 | $7.55 |
Technical Indicators
Market Signals| Indicator | OSUR | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 47.23 | 49.89 |
| Support Level | $2.87 | $3.70 |
| Resistance Level | $3.24 | $4.38 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 29.26 | 19.90 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.